STAT3 and acute lymphoblastic leukemia: Notably, we demonstrated that combined inhibition of PI3K and STAT3 with GDC-0032 and nifuroxazide in T-ALL cells as well as in xenograft tumor models of T-ALL resulted in maximal suppression of cellular proliferation and tumor progression in vivo.